Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Shares Outstanding (2016 - 2025)

Avanos Medical's Shares Outstanding history spans 7 years, with the latest figure at -$580000.0 for Q4 2021.

  • For Q4 2021, Shares Outstanding fell 101.21% year-over-year to -$580000.0; the TTM value through Dec 2021 reached -$580000.0, down 101.21%, while the annual FY2021 figure was -$580000.0, 101.21% down from the prior year.
  • Shares Outstanding for Q4 2021 was $48.2 million at Avanos Medical, up from $47.9 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $48.2 million in Q4 2021 and bottomed at -$206000.0 in Q4 2019.
  • The 5-year median for Shares Outstanding is $172000.0 (2019), against an average of $20.4 million.
  • The largest annual shift saw Shares Outstanding surged 47.01% in 2019 before it plummeted 101.21% in 2021.
  • A 5-year view of Shares Outstanding shows it stood at $46.9 million in 2017, then rose by 1.12% to $47.4 million in 2018, then increased by 0.61% to $47.7 million in 2019, then grew by 0.39% to $47.9 million in 2020, then plummeted by 101.21% to -$580000.0 in 2021.
  • Per Business Quant, the three most recent readings for AVNS's Shares Outstanding are -$580000.0 (Q4 2021), $47.9 million (Q4 2020), and $47.7 million (Q4 2019).